HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial

AIDS

Volumn 16, Issue 6, 2002, Pages 877-887

  Jabs, Douglas A ^a   Kaplan Gilpin, Adele M ^a   Min, Yuan I ^a   Erice, Alejo ^a   Kempen, John H ^a   Quinn, Thomas C ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

AIDS; Antigenemia; Cytomegalovirus; HIV; Randomized clinical trial; Viral load; Viremia

Indexed keywords

SEVIRUMAB; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RETINITIS; RISK FACTOR; TREATMENT PLANNING; VIREMIA; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, MONOCLONAL; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DNA, VIRAL; FEMALE; HUMANS; MALE; PLACEBOS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0037066356     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200204120-00007     Document Type: Article

References (37)

1. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine
2. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression
3. Ocular manifestations of HIV infection
4. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus
5. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis
6. AIDS ophthalmology: A period of transition
7. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
8. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: Baseline CMV load dictates time to disease and survival
9. Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS
10. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients
11. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease
12. Predictive value of cytomegalovirus (CMV) antigenemia and digene hybrid capture DNA assays for CMV disease in human immunodeficiency virus-infected patients
13. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
14. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS
15. Usefulness of the pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS
16. Role of the cytomegalovirus (CMV)-antigenemia assay as a predictive and follow-up detection tool for CMV disease in AIDS patients
17. pp65 Antigenemia as a marker of future CMV disease and mortality in HIV-infected patients
18. Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis
19. Cytomegalovirus retinitis in AIDS patients: Influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival
20. Cytomegalovirus antigenemia surveillance in the treatment of cytomegalovirus disease in AIDS patients
21. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome
22. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescent and adults
23. Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for detection of CMV in polymorphonuclear leukocytes
24. COBAS AMPLICOR: Fully automated RNA and DNA amplification and detection system for routine diagnostic PCR
25. Maternal levels of plasma HIV-1 RNA and the risk of perinatal transmission
26. Regression models and life tables
27. Longitudinal data analysis using generalized linear models
28. Cytomegalovirus retinitis and viral resistance: Ganciclovir resistance
29. Cytomegalovirus retinitis and viral resistance: 3. Culture results
30. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: Implications for therapy
31. Phase I study of safety and pharmacokinetics of a human anticytomegalovirus monoclonal antibody in allogeneic bone marrow transplant recipients
32. In vitro neutralization of cytomegalovirus strains by a human monoclonal antibody, MSL-109
33. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monocolonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation
34. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis
35. CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy
36. Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy